In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae. - Wikidata - awgldk - TriplyDB

In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae.

In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae.

http://www.wikidata.org/entity/Q37881176

about

In vitro and in vivo activities of sitafloxacin against Chlamydia spp Inhibitory activities of quinolones against DNA gyrase of Chlamydia pneumoniae.In vitro activities of gemifloxacin (SB 265805, LB20304) against recent clinical isolates of Chlamydia pneumoniae.

P2860

Q33983469-B09894A1-609F-446E-8601-201A85CC666A Q37869167-7DD3D5D8-9D2E-4318-B694-A139AAD18A43 Q37877492-516CAF30-BF1D-4C24-83F4-A1E8F54A35DD

P2860

In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae.

http://www.wikidata.org/entity/Q37881176

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 1998

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae.

@en

In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae.

@nl

type

label

In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae.

@en

In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae.

@nl

prefLabel

In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae.

@en

In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae.

@nl

P1433

Q37881176-F8E1121C-6345-4312-9083-8DFC6549BD8B

P1476

Q37881176-30708DA5-4E48-40A5-AF75-069323258F6F

P2093

Q37881176-44BEAA70-3255-4EF2-8B5D-A2BDC5481292

Q37881176-A987A34D-DFE1-4FF9-B0BF-B51B8EBC2AE0

P2860

Q37881176-05D84571-9A2F-4FF2-B588-B83DE04504DC

Q37881176-22ECE7DA-0131-438B-8C15-3F67A0BD295D

Q37881176-44C21294-2526-4302-8772-20D1D5529402

Q37881176-5568968C-64A0-4D27-9125-FEDD90328902

Q37881176-62E5C58D-BEFA-44B6-9E1D-D94155FB4A67

Q37881176-90071851-4567-43AA-8572-C58E4F9785EB

Q37881176-952A623C-BB41-441A-BCE8-05A7A6E8A597

Q37881176-9B44065F-C4E4-4F2C-82E2-F36E25EB27BE

Q37881176-9D35CA11-B889-40C4-AD9D-4060FD192B3C

Q37881176-A16C4824-D79E-4AF2-9137-D03005FA4551

P304

Q37881176-C537793E-A0D8-4460-A94B-C2CBF4E66725

P31

Q37881176-2A8F6DE9-43CE-4B84-8390-CF1528F3CB3B

P356

Q37881176-9113D1B1-3378-4D44-9364-683524FB7F2C

P407

Q37881176-E81EAE47-4B18-4ADC-A4D2-A6A16C4DD693

P433

Q37881176-00537B54-9BC4-4102-B6B7-014F4189D76C

P478

Q37881176-8ED747FB-E8A6-4685-832C-EE7B7763A211

P577

Q37881176-F449D377-E64A-41EE-A87C-83EAFD124F60

P698

Q37881176-D6EF5627-F329-4D1E-A133-1564E5413A10

P932

Q37881176-F3F0B5F5-64F6-46C7-AF5C-D228432EA794

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae

@en

P2093

Hammerschlag MR

http://www.w3.org/2001/XMLSchema#string

Roblin PM

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro activity of BAY 12-8039, a new fluoroquinolone

Ofloxacin versus standard therapy in treatment of community-acquired pneumonia requiring hospitalization. Pneumonia Study Group.

In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.

A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia.

In vitro activity of trovafloxacin against Chlamydia pneumoniae

In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae

Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate.

In vitro activities of OPC-17116, a new quinolone; ofloxacin; and sparfloxacin against Chlamydia pneumoniae.

Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae.

In vitro activities of five quinolones against Chlamydia pneumoniae.

P304

951-952

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.42.4.951

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

1998-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9559818

http://www.w3.org/2001/XMLSchema#string

P932

105577

http://www.w3.org/2001/XMLSchema#string